Susan Berson and Brent Henry Recognized as Health Care Trailblazers by the National Law Journal
Filter by:
Mintz Advises the Placement Agents in CAMP4’s up to $100 Million Private Placement
September 12, 2025
Mintz advised the placement agents in connection with CAMP4's up to $100 million private placement. The private placement included upfront gross proceeds of $50 million in exchange for common stock (and pre-funded warrants in lieu of common stock for certain investors). In addition, CAMP4 will be eligible to receive up to an additional $50 million in gross proceeds in exchange for common stock (and pre-funded warrants for certain investors), subject to achieving pre-specified milestones, including receipt of regulatory clearance to initiate a Phase 1/2 clinical trial in SYNGAP patients with its development candidate, CMP-SYNGAP-01.
Transparency, New Players Shake up PBM Landscape
September 11, 2025
The Deal quoted Member Theresa Carnegie in a recent article about how regulatory pressure on pharmacy benefit managers (PBMs) has sparked innovation and opened up investment opportunities in the industry. Increased scrutiny of larger PBMs over concerns about competition and drug prices has prompted newer PBMs to emphasize transparency.
Three Mintz Attorneys Recognized in Lawdragon’s 2025 500 Leading Global Real Estate Lawyers
September 11, 2025
Mintz members Daniel Guggenheim, Rebecca Lee, and Jeffrey Moerdler have been recognized by Lawdragon in its 2025 500 Leading Global Real Estate Lawyers list. The three attorneys were also recognized in last year’s inaugural edition of the list.
Mintz Advises the Underwriters in Ondas Holdings’ $230 Million Underwritten Offering
September 11, 2025
Mintz advised the underwriters in connection with the $230 million underwritten offering by Ondas Holdings Inc. of 46,000,000 shares of its common stock, which includes 6,000,000 shares of common stock sold pursuant to the exercise in full by the underwriters of their option to purchase additional shares of common stock.
Mintz Recognized in LMG’s “Life Sciences Americas Awards” 2025
September 08, 2025
Mintz received a pair of awards at LMG’s 2025 “Life Sciences Americas Awards” which recognize the region’s “most distinguished practitioners and their firms for their exemplary work in the Life Sciences legal practice over the past twelve months.”
How AI Is Disrupting LevFin, Part Two — Decoding AI Compliance
September 8, 2025
Member Steve Osborn was quoted in a 9fin article examining compliance concerns related to AI technologies and the steps being taken by regulators and leveraged credit market participants. The article highlights differing views among companies about whether AI could introduce decision bias, particularly in areas like underwriting.